Ampio Pharmaceuticals Inc. (AMPE) focuses on research and development of drugs aimed at managing inflammatory illnesses. One of the major milestones of this pharmaceutical company is the development of a drug aimed at treating pain caused by osteoarthritis of the knee(Ampio Pharmaceuticals, 2018). The company has conducted pre-clinical and clinical research on the constituents of the drug it is creating. The drug is expected to be effective in treatment of immune mediated illnesses and inflammatory conditions.
The progression made by Ampio is also evidenced by its development of an injection to treat osteoarthritis of the knee. This injection will be intra-articular and the company has began its trial. Additionally, the organization continues to conduct research on inflammatory conditions. The involvement of accompany is research is what propels it to make progress. The company conveys information about its research to the public through various publications.
Moreover, the progress made by AMPE pharmaceutical company is revealed by the number of patents it has. The company has fifty-six patents which it has been issued across the world. Having the company operating and recognized across the word is an indication of progress. It shows that the organization’s activities have increased and that it is performing more duties.
Ampio Pharmaceuticals. (2018). Ampio Pharmaceuticals. Retrieved from https://ampiopharma.com/